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ROSENBERG (1977) put forward a hypo-
thesis concerning the mechanism of anti-
cancer activity of cis-platinum complexes
in vivo. According to this hypothesis, the
simple cytotoxic effect is accompanied by
an enhanced expression of cancer antigens
on the surface of malignant cells. There-
fore, the observed regression of malignant
growth is at least partly due to the
immunological response of the organism.
An example supporting this assumption is
the growth kinetics of ascites sarcoma 180
in ICR mice after injection ofcis-dichloro-
diammine cis-platinum (Rosenberg, 1978).
For 4 days following injection the number
of tumour cells increases. From the 5th
day it falls, reaching zero in a cured
animal. According to Rosenberg, this
result is consistent with the suggestion
that surviving cells are destroyed by the
immune system. The hypothesis implies
the existence of a ready defensive mech-
anism which can be stimulated by cis-
platin-induced changes in the malignant
cell surface.
In an attempt to test this hypothesis,
we used cis-dichloro bis-(cyclopentyl-
amine) platinum (II) (cis-PAD) and
L5178Y-R murine leukaemic cells. These
cells are very sensitive to cis-PAD in
vitro (Szumiel, 1979) and form ascites
tumours in DBA/2 mice. The Pt complex
is effective in vivo in mice against leuk-
aemia L 1210, Rauscher leukaemia
MCDV-12 and Grardner lymphoma OG
(Speer et al., 1975). Treating L5178Y-R
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cells in vitro with a cis-PAD dose which
reduces survival to a known level, and
injecting the treated cells into DBA/2
mice, allows one to differentiate between
the cytotoxic effect of the drug and the
possible influence of the immtinological
response on growth in vivo.
Cis-PAD was kindly provided by Dr
T. A. Connors and by Johnson Matthey
& Co. Ltd (London).
L5178Y-R cell culture was carried out
in Fischer's medium (GIBCO) with 8°/
bovine serum (Pan'stwowa Wytwornia
Surowic i Szczepionek, Lublin, Poland) as
described previously (Szumiel, 1979).
Drug treatment was carried out in the
following way. A 100ml culture of
L5178Y-R cells containing - 3 x 107 cells
was treated with cis-PAD at a concentra-
tion of 15 [kg/ml for 1 h at 37°C. The
details of treatment were reported earlier
(Szumiel, 1979). After completion of the
treatment the culture was centrifuged,
cells washed twice with warm medium and
resuspended in , 15 ml of medium for
immediate injection into mice (106 cells/
0-5 ml/mouse).
Fifty DBA/2 mice were divided into 5
groups and inoculated with untreated and/
or cis-PAD treated L5178Y-R cells. Two
groups received 103 or 5 x 105 untreated
cells. Two groups were inoculated with
1 03 or 5 x 1 05 cells followed two days later
by 106 cms-PAD-treated cells. The 2-day
interval was chosen with the intention of
mimicking the usual sequence of events inGROWTH IN VIVO OF PAD-TREATED L5178Y-R CELLS 117
TABLE.-Life span of mice receiving L5178Y-R cells treated in vitro with cis-PAD
Cell number injected i.p.
r--- + Average
Group cis-PAD-treated cells Total life
of Untreated (Day 2) viable span
DBA/2 cells - cells (days)
mice (Day 0) Total Surviving injected +s.e.
A 103 - 103 24*3+1-0
B 103 106 103 2x 103 22-0+0-6
C 5x 105 -5x 105 16-1+05
D 5 x 105 106 103 5-01 x 105 16-9+0K3
E 106 103 103 22-7 + 0-6
experiments in vivo, where tumour-cell
inoculation is followed by drug injection
1-2 days later. The dose of drug used
reduces cell survival to 10-3 in experi-
ments in vitro (Szumiel, 1979); therefore,
from 106 injected cells 103 can be expected
to be able to divide. The last group re-
ceived only cis-PAD treated cells (106).
The experimental schedule and the
results are shown in the Table. Prolonga-
tion of life span of mice from Groups B
and D, compared with those from Groups
A and C could be expected, according to
Rosenberg's hypothesis, and ascribed to
the action of the immune system. How-
ever, average life spans of mice that re-
ceived both drug-treated and untreated
cells (Groups B, D) are very close to the
life span of mice receiving only untreated
cells (Groups A, C). In Group E, receiving
only drug-treated cells, death was ob-
served after the interval expected for the
number of viable cells injected (cf. Group
A). These results indicate that growth in
vivo of cis-PAD-treated cells can be
interpreted solely in terms of a direct
cytotoxic drug effect.
These results contrast with those ob-
tained for ascites sarcoma 180, where
mice were inoculated with 4 x 106 tumour
cells on Day 0 and injected with cis-platin
on Day 1. In that experimental system
(Rosenberg, 1978) a decrease of cell num-
ber started on Day 5 and continued to fall
to zero in cured animals. The difference
between these two types of malignant cell
may be the reason for the discrepancy in
experimental results. Our results indicate
that Rosenberg's (1977) hypothesis cannot
be applied to L5178Y-R cells.
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